508 related articles for article (PubMed ID: 14960498)
1. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome.
Andersen SM; Ling CC; Zhang P; Townson K; Willison HJ; Bundle DR
Org Biomol Chem; 2004 Apr; 2(8):1199-212. PubMed ID: 15064799
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
6. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
8. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
9. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
10. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding.
Jacobs BC; O'Hanlon GM; Bullens RW; Veitch J; Plomp JJ; Willison HJ
Brain; 2003 Oct; 126(Pt 10):2220-34. PubMed ID: 12876146
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
15. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
Kusunoki S
Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
[TBL] [Abstract][Full Text] [Related]
16. Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies.
Townson K; Boffey J; Nicholl D; Veitch J; Bundle D; Zhang P; Samain E; Antoine T; Bernardi A; Arosio D; Sonnino S; Isaacs N; Willison HJ
Glycobiology; 2007 Mar; 17(3):294-303. PubMed ID: 17145744
[TBL] [Abstract][Full Text] [Related]
17. Complete recovery of an aged patient with Guillain-Barré syndrome associated with multiple IgM anti-ganglioside antibodies.
Furiya Y; Hirano M; Kusunoki S; Ueda M; Sugie K; Nishiwaki T; Ueno S
Muscle Nerve; 2008 Dec; 38(6):1630-3. PubMed ID: 19016534
[TBL] [Abstract][Full Text] [Related]
18. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
Yuki N; Uncini A
Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
[TBL] [Abstract][Full Text] [Related]
20. Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies.
Willison HJ
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S16-20. PubMed ID: 12690656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]